Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 174 Neoplasm Metastasis 139 Neoplasms 133 Leukemia, Myeloid, Acute 127 Colorectal Neoplasms 126 Breast Neoplasms 113 Melanoma 88 Ovarian Neoplasms 87 Prostatic Neoplasms 86 Recurrence 84 Multiple Myeloma 79 Pancreatic Neoplasms 74 Squamous Cell Carcinoma of Head and Neck 72 Glioblastoma 71 Lung Neoplasms 70 Lymphoma, Non-Hodgkin 62 Myelodysplastic Syndromes 60 Triple Negative Breast Neoplasms 56 Stomach Neoplasms 52 Glioma 52 Precursor Cell Lymphoblastic Leukemia-Lymphoma 49 Endometrial Neoplasms 47 Carcinoma, Renal Cell 47 Small Cell Lung Carcinoma 46 Lymphoma, Large B-Cell, Diffuse 44 Brain Neoplasms 43 Carcinoma, Hepatocellular 41 Sarcoma 39 Advanced Solid Tumors 39 Lymphoma, Follicular 38

Interventions

copanlisib 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × HER2 Positive Breast Cancer × 90 days × Clear all

NCT02705859 2026-04-13

Panther

Cancer Trials Ireland

Phase 1 Completed

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡